查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1830680

2025年3D生物列印人體組織全球市場報告

3D Bioprinted Human Tissue Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，3D生物列印人體組織的市場規模迅速擴張，從2024年的17億美元成長到2025年的19.3億美元，複合年成長率為13.7%。預測期內的成長主要源自於器官移植需求的不斷成長、慢性病盛行率的上升、再生醫學投資的不斷成長、幹細胞研究的不斷拓展以及個人化醫療的日益普及。

預計未來幾年，3D生物列印人體組織市場將快速成長，到2029年將達到31.8億美元，年複合成長率（CAGR）為13.3%。預測期內的成長動力包括器官移植需求的不斷成長、慢性病的流行、再生醫學投資的不斷成長、幹細胞研究的持續擴展以及個性化醫療應用的日益普及。預計這段時期的主要趨勢包括生物墨水技術的進步、組織工程的創新、幹細胞生物列印的快速發展、研發活動的不斷擴展以及多材料、多細胞列印系統的出現。

3D生物列印人體組織是指利用生物列印技術創建的3D結構，該技術涉及逐層沉積活細胞、生物墨水和生物材料來創建組織。 3D生物列印組織的主要目標是為再生醫學、藥物測試、疾病建模以及未來的器官移植等應用創建功能模型。

3D 生物列印人體組織的主要類型包括皮膚、軟骨、肝臟、骨骼和心臟。皮膚組織是指旨在模仿人體保護性外皮的生物列印層，用於創傷治療和移植應用。使用各種生物列印技術，包括基於擠壓的系統、噴墨生物列印、雷射輔助生物列印、微流體、聲學方法、磁浮以及混合或 4D 方法。可以使用多種材料，包括天然生物材料、合成生物材料、去細胞細胞外基質、水凝膠和複合材料。這些組織用於組織工程、整容手術、藥物測試和開發以及食品測試等領域，並被製藥公司、生物技術公司、學術和研究機構、受託研究機構以及醫院和診所等最終用戶所使用。

2025年春季美國關稅的突然上調及其引發的貿易摩擦正對製藥公司造成嚴重衝擊。高利潤率的學名藥製造商尤其容易受到影響，一些公司正在縮減低收益藥品的生產。由於關稅導致的專用試劑短缺，生物技術公司正面臨臨床試驗延遲。為此，該產業正在印度和歐洲擴大原料藥的生產，增加庫存，並遊說獲得基本藥物的貿易豁免。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分，該系列提供 3D 生物列印人體組織市場統計數據，包括全球市場規模、區域佔有率、3D 生物列印人體組織市場佔有率的競爭對手、詳細的 3D 生物列印人體組織細分市場、市場趨勢和機遇，以及您在 3D 生物列印方面取得成功所需的人體組織資料。本 3D 生物列印人體組織市場研究報告對該行業的現狀和未來趨勢進行了詳細分析，為您提供所需的一切觀點。

器官移植需求的不斷成長預計將在未來幾年推動3D生物列印人體組織市場的成長。器官移植是一種醫療程序，將器官從捐贈者轉移到接受者，以替換受損或功能障礙的器官。隨著患者尋求能夠縮短等待時間、提高存活率並提供可靠移植方案的救命療法，對此類程序的需求正在成長。 3D生物列印人體組織提供了一種突破性的替代方案，它能夠創建患者特異性的功能性組織，從而降低排斥風險並減少對捐贈器官的依賴。例如，2024年1月，美國衛生與公眾服務部器官採購和移植網路報告稱，2023年共有46,632例來自活體和死者捐贈的器官移植，比2022年成長8.7%，比2021年成長12.7%。因此，器官移植需求的不斷成長正在推動3D生物列印人體組織市場的成長。

3D生物列印人體組織市場的公司正在推動患者來源樣本最佳化等創新，以提高藥物研發、疾病研究和再生醫學領域組織模型的準確性和個人化。患者來源樣本最佳化是指高效利用有限的患者細胞資源，創建多個高品質、生物相關的3D組織模型，從而獲得更準確的研究結果。例如，2025年1月，澳洲生物技術公司Inventia Life Science Pty Ltd.將RASTRUM解決方案引入其產品組合，從而能夠快速、可重複且準確地創建複雜的3D人體組織模型。這些模型忠實地模擬了真實的人體組織，可用於藥物測試、疾病建模和再生醫學。透過先進的按需滴加生物列印技術，該平台實現了標準實驗室培養板格式的3D細胞培養的自動化和規模化，從而減少了人工操作並降低了差異性。這項進步支持高通量實驗並獲得一致且生物相關的結果，加速了藥物發現並提高了臨床前研究的可預測性。

2022年5月，總部位於瑞典的生命科學和生物融合技術供應商BICO Group AB收購了Allegro 3D Inc.，收購金額未揭露。此次收購旨在透過整合Allegro 3D先進的基於光的微影術技術，擴展BICO的生物列印產品組合，並加速組織工程和再生醫學領域創新產品的開發。 Allegro 3D是一家總部位於美國的3D生物列印人體組織製造商。

3D生物列印人體組織市場由提供生物列印組織商業性生產、藥物測試和開發以及研發服務等服務的營業單位所獲得的收益所構成。市場價值包括服務提供者銷售的或包含在其服務產品中的任何相關商品的價值。 3D生物列印人體組織市場還包括生物墨水、植入物組織結構、合成聚合物、天然聚合物、水凝膠和支架材料的銷售。此市場的價值是指“出廠價”，即商品製造商或生產商向其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接向最終客戶銷售的商品價值。該市場中的商品價值還包括商品製造商銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球 3D 生物列印人體組織：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球3D生物列印人體組織市場：成長率分析
  • 全球3D生物列印人體組織市場表現：規模與成長，2019-2024年
  • 全球3D生物列印人體組織市場預測：規模與成長，2024-2029年，2034年
  • 全球 3D 生物列印人體組織：總目標市場 (TAM)

第6章 市場細分

  • 全球3D生物列印人體組織市場（按組織類型、性能和預測），2019-2024年，2024-2029年，2034年
  • 皮膚
  • 軟骨
  • 肝
  • 骨
  • 心
  • 其他組織類型
  • 全球3D生物列印人體組織市場（依技術、性能及預測），2019-2024年，2024-2029年，2034年
  • 擠壓底座
  • 噴墨生物列印
  • 雷射輔助生物列印
  • 微流體和聲學
  • 磁浮
  • 混合或 4D
  • 全球3D生物列印人體組織市場：依材料、性能及預測，2019-2024年、2024-2029年、2034年
  • 天然生醫材料
  • 合成生醫材料
  • 去細胞細胞外基質
  • 水凝膠
  • 複合材料
  • 其他成分
  • 全球3D生物列印人體組織市場：應用、績效及預測（2019-2024年、2024-2029年及2034年）
  • 組織工程
  • 整容手術
  • 藥物測試與開發
  • 食品檢驗
  • 全球 3D 生物列印人體組織市場：按最終用戶、實際和預測，2019-2024 年、2024-2029 年、2034 年
  • 製藥公司
  • 生技公司
  • 學術研究機構
  • 合約研究組織
  • 醫院和診所
  • 全球 3D 生物列印人體組織市場：依皮膚類型細分，實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 創傷治療應用
  • 化妝品測試模型
  • 皮膚移植置換
  • 全球 3D 生物列印人體組織市場：按軟骨類型、性能和預測細分，2019-2024 年、2024-2029 年、2034 年
  • 關節修復模型
  • 鼻部重組
  • 耳部重組
  • 全球 3D 生物列印人體組織市場：按肝臟、類型、性能和預測細分，2019-2024 年、2024-2029 年、2034 年
  • 毒性測試模型
  • 疾病模型
  • 移植調查
  • 全球 3D 生物列印人體組織市場：依骨骼類型細分，實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 整形外科植入
  • 顱骨修復模型
  • 移植骨替代物
  • 全球 3D 生物列印人體組織市場：按心臟、類型、性能和預測細分，2019-2024 年、2024-2029 年、2034 年
  • 心臟補片的開發
  • 心臟瓣膜模型
  • 心肌再生
  • 全球 3D 生物列印人體組織市場：依組織類型細分，實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 腎臟模型
  • 肺組織結構
  • 胰臟組織模型

第7章 區域和國家分析

  • 全球3D生物列印人體組織市場：區域表現與預測（2019-2024年、2024-2029年、2034年）
  • 全球 3D 生物列印人體組織市場：國家、績效及預測（2019-2024 年、2024-2029 年及 2034 年）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 3D生物列印人體組織市場：競爭格局
  • 3D生物列印人體組織市場：公司簡介
    • 3D Systems Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Inventia Life Science PTY LTD. Overview, Products and Services, Strategy and Financial Analysis
    • Aspect Biosystems Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Cellink Global AB Overview, Products and Services, Strategy and Financial Analysis
    • Prellis Biologics Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Cyfuse Biomedical KK
  • Poietis SAS
  • Fluidform LLC
  • Tissuelabs
  • Brinter Oy
  • EpiBone Inc.
  • Carcinotech Ltd.
  • VoxCell BioInnovation Inc.
  • Organovo Holdings Inc.
  • Biolife 4D
  • Vivax-bio
  • CollPlant Biotechnologies Ltd.
  • Xolo
  • Copner Biotech
  • TissueTinker

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029年3D生物列印人體組織市場：提供新機會的國家
  • 2029年3D生物列印人體組織市場：細分領域帶來新機會
  • 2029年3D生物列印人體組織市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r37667

3D bioprinted human tissue refers to three-dimensional structures produced using bioprinting technology, which deposits living cells, bioinks, and biomaterials layer by layer to fabricate tissue. The primary goal of 3D bioprinted tissues is to create functional models for applications such as regenerative medicine, drug testing, disease modeling, and, in the future, organ transplantation.

The primary types of 3D bioprinted human tissue include skin, cartilage, liver, bone, heart, and others. Skin tissue refers to bioprinted layers designed to mimic the body's protective outer covering, with applications in wound healing and grafting. Various bioprinting technologies are used, including extrusion-based systems, inkjet bioprinting, laser-assisted bioprinting, microfluidic and acoustic methods, magnetic levitation, and hybrid or 4D approaches. A wide range of materials can be employed, such as natural biomaterials, synthetic biomaterials, decellularized extracellular matrices, hydrogels, composite materials, and others. These tissues are applied in fields such as tissue engineering, cosmetic surgery, drug testing and development, and food testing, and are utilized by end users including pharmaceutical companies, biotechnology firms, academic and research institutions, contract research organizations, and hospitals and clinics.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The 3D bioprinted human tissue market research report is one of a series of new reports from The Business Research Company that provides 3D bioprinted human tissue market statistics, including 3D bioprinted human tissue industry global market size, regional shares, competitors with a 3D bioprinted human tissue market share, detailed 3D bioprinted human tissue market segments, market trends and opportunities, and any further data you may need to thrive in the 3D bioprinted human tissue industry. This 3D bioprinted human tissue market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The 3D bioprinted human tissue market size has grown rapidly in recent years. It will grow from $1.70 billion in 2024 to $1.93 billion in 2025 at a compound annual growth rate (CAGR) of 13.7%. The growth in the historic period can be attributed to the rising demand for organ transplantation, the increasing prevalence of chronic diseases, greater investment in regenerative medicine, the expansion of stem cell research, and the growing adoption of personalized medicine.

The 3D bioprinted human tissue market size is expected to see rapid growth in the next few years. It will grow to $3.18 billion in 2029 at a compound annual growth rate (CAGR) of 13.3%. The growth in the forecast period can be attributed to the rising demand for organ transplantation, the increasing prevalence of chronic diseases, greater investment in regenerative medicine, the continued expansion of stem cell research, and the growing use of personalized medicine. Key trends anticipated during this period include advancements in bio-ink technologies, innovations in tissue engineering, rapid progress in stem cell bioprinting, expanding research and development activities, and the emergence of multi-material and multi-cell printing systems.

The rising demand for organ transplants is expected to drive the growth of the 3D bioprinted human tissue market in the coming years. Organ transplantation is a medical procedure in which organs are transferred from a donor to a recipient to replace damaged or failing organs. The growing demand for these procedures stems from patients seeking life-saving treatments that reduce waiting times, improve survival rates, and provide reliable transplant solutions. 3D bioprinted human tissue offers a breakthrough alternative by enabling the creation of patient-specific, functional tissues that lower the risk of rejection and reduce reliance on donor organs. For instance, in January 2024, the Organ Procurement and Transplantation Network, a US-based Department of Health and Human Services entity, reported that organ transplants from living and deceased donors totaled 46,632 in 2023, an 8.7% increase over 2022 and a 12.7% increase over 2021 marking the first time more than 40,000 organ transplants were performed in a single year. Therefore, the increasing demand for organ transplants is fueling growth in the 3D bioprinted human tissue market.

Companies in the 3D bioprinted human tissue market are advancing technological innovations such as patient-derived sample optimization to enhance the accuracy and personalization of tissue models for drug discovery, disease research, and regenerative medicine. Patient-derived sample optimization refers to the efficient use of limited patient cells to generate multiple high-quality, biologically relevant 3D tissue models for more precise research outcomes. For example, in January 2025, Inventia Life Science Pty Ltd., an Australia-based biotechnology firm, introduced the RASTRUM solution within its product suite to enable the rapid, reproducible, and precise creation of complex 3D human tissue models. These models closely mimic real human tissues for use in drug testing, disease modeling, and regenerative medicine. Using advanced drop-on-demand bioprinting technology, the platform automates and scales the production of 3D cell cultures in standard lab plate formats, reducing manual work and variability. This advancement supports high-throughput experiments with consistent and biologically relevant results, accelerating discoveries and improving preclinical research predictability.

In May 2022, BICO Group AB, a Sweden-based provider of life science and bioconvergence technologies, acquired Allegro 3D Inc. for an undisclosed amount. This acquisition was aimed at expanding BICO's bioprinting portfolio by incorporating Allegro 3D's advanced light-based photolithography technology to accelerate the development of innovative products in tissue engineering and regenerative medicine. Allegro 3D Inc. is a US-based manufacturer of 3D bioprinted human tissues.

Major players in the 3d bioprinted human tissue market are 3D Systems Corporation, Inventia Life Science PTY LTD., Aspect Biosystems Ltd., Cellink Global AB, Prellis Biologics Inc., Cyfuse Biomedical K.K., Poietis SAS, Fluidform LLC, Tissuelabs, Brinter Oy, EpiBone Inc., Carcinotech Ltd., VoxCell BioInnovation Inc., Organovo Holdings Inc., Biolife 4D, Vivax-bio, CollPlant Biotechnologies Ltd., Xolo, Copner Biotech, and TissueTinker.

North America was the largest region in the 3D bioprinted human tissue market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in 3D bioprinted human tissue market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the 3D bioprinted human tissue market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The 3D bioprinted human tissue market consists of revenues earned by entities by providing services such as commercial manufacturing of bioprinted tissues, drug testing and development, and research and development services. The market value includes the value of related goods sold by the service provider or included within the service offering. The 3D bioprinted human tissue market also includes sales of bioinks, tissue constructs for transplantation, synthetic and natural polymers, hydrogels, and scaffold materials. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

3D Bioprinted Human Tissue Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on 3d bioprinted human tissue market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for 3d bioprinted human tissue ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The 3d bioprinted human tissue market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Tissue Type: Skin; Cartilage; Liver; Bone; Heart; Other Tissue Types
  • 2) By Technology: Extrusion-Based; Inkjet Bioprinting; Laser-Assisted Bioprinting; Microfluidic And Acoustic; Magnetic Levitation; Hybrid Or 4D
  • 3) By Materials: Natural Biomaterials; Synthetic Biomaterials; Decellularized Extracellular Matrices; Hydrogels; Composite Materials; Other Materials
  • 4) By Application: Tissue Engineering; Cosmetic Surgery; Drug Testing And Development; Food Testing
  • 5) By End-User: Pharmaceutical Companies; Biotechnology Firms; Academic Research Institutions; Contract Research Organizations; Hospitals And Clinics
  • Subsegments:
  • 1) By Skin: Wound Healing Applications; Cosmetic Testing Models; Skin Graft Replacements
  • 2) By Cartilage: Joint Repair Models; Nasal Reconstruction; Ear Reconstruction
  • 3) By Liver: Toxicity Testing Models; Disease Modeling; Transplant Research
  • 4) By Bone: Orthopedic Implants; Cranial Repair Models; Bone Graft Substitutes
  • 5) By Heart: Cardiac Patch Development; Heart Valve Models; Myocardial Regeneration
  • 6) By Other Tissue Types: Kidney Models; Lung Tissue Constructs; Pancreatic Tissue Models
  • Companies Mentioned: 3D Systems Corporation; Inventia Life Science PTY LTD.; Aspect Biosystems Ltd.; Cellink Global AB; Prellis Biologics Inc.; Cyfuse Biomedical K.K.; Poietis SAS; Fluidform LLC; Tissuelabs; Brinter Oy; EpiBone Inc.; Carcinotech Ltd.; VoxCell BioInnovation Inc.; Organovo Holdings Inc.; Biolife 4D; Vivax-bio; CollPlant Biotechnologies Ltd.; Xolo; Copner Biotech; TissueTinker.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. 3D Bioprinted Human Tissue Market Characteristics

3. 3D Bioprinted Human Tissue Market Trends And Strategies

4. 3D Bioprinted Human Tissue Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global 3D Bioprinted Human Tissue Growth Analysis And Strategic Analysis Framework

  • 5.1. Global 3D Bioprinted Human Tissue PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global 3D Bioprinted Human Tissue Market Growth Rate Analysis
  • 5.4. Global 3D Bioprinted Human Tissue Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global 3D Bioprinted Human Tissue Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global 3D Bioprinted Human Tissue Total Addressable Market (TAM)

6. 3D Bioprinted Human Tissue Market Segmentation

  • 6.1. Global 3D Bioprinted Human Tissue Market, Segmentation By Tissue Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Skin
  • Cartilage
  • Liver
  • Bone
  • Heart
  • Other Tissue Types
  • 6.2. Global 3D Bioprinted Human Tissue Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Extrusion-Based
  • Inkjet Bioprinting
  • Laser-Assisted Bioprinting
  • Microfluidic And Acoustic
  • Magnetic Levitation
  • Hybrid Or 4D
  • 6.3. Global 3D Bioprinted Human Tissue Market, Segmentation By Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Natural Biomaterials
  • Synthetic Biomaterials
  • Decellularized Extracellular Matrices
  • Hydrogels
  • Composite Materials
  • Other Materials
  • 6.4. Global 3D Bioprinted Human Tissue Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Tissue Engineering
  • Cosmetic Surgery
  • Drug Testing And Development
  • Food Testing
  • 6.5. Global 3D Bioprinted Human Tissue Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pharmaceutical Companies
  • Biotechnology Firms
  • Academic Research Institutions
  • Contract Research Organizations
  • Hospitals And Clinics
  • 6.6. Global 3D Bioprinted Human Tissue Market, Sub-Segmentation Of Skin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Wound Healing Applications
  • Cosmetic Testing Models
  • Skin Graft Replacements
  • 6.7. Global 3D Bioprinted Human Tissue Market, Sub-Segmentation Of Cartilage, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Joint Repair Models
  • Nasal Reconstruction
  • Ear Reconstruction
  • 6.8. Global 3D Bioprinted Human Tissue Market, Sub-Segmentation Of Liver, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Toxicity Testing Models
  • Disease Modeling
  • Transplant Research
  • 6.9. Global 3D Bioprinted Human Tissue Market, Sub-Segmentation Of Bone, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Orthopedic Implants
  • Cranial Repair Models
  • Bone Graft Substitutes
  • 6.10. Global 3D Bioprinted Human Tissue Market, Sub-Segmentation Of Heart, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cardiac Patch Development
  • Heart Valve Models
  • Myocardial Regeneration
  • 6.11. Global 3D Bioprinted Human Tissue Market, Sub-Segmentation Of Other Tissues, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Kidney Models
  • Lung Tissue Constructs
  • Pancreatic Tissue Models

7. 3D Bioprinted Human Tissue Market Regional And Country Analysis

  • 7.1. Global 3D Bioprinted Human Tissue Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global 3D Bioprinted Human Tissue Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific 3D Bioprinted Human Tissue Market

  • 8.1. Asia-Pacific 3D Bioprinted Human Tissue Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific 3D Bioprinted Human Tissue Market, Segmentation By Tissue Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific 3D Bioprinted Human Tissue Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific 3D Bioprinted Human Tissue Market, Segmentation By Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China 3D Bioprinted Human Tissue Market

  • 9.1. China 3D Bioprinted Human Tissue Market Overview
  • 9.2. China 3D Bioprinted Human Tissue Market, Segmentation By Tissue Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China 3D Bioprinted Human Tissue Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China 3D Bioprinted Human Tissue Market, Segmentation By Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India 3D Bioprinted Human Tissue Market

  • 10.1. India 3D Bioprinted Human Tissue Market, Segmentation By Tissue Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India 3D Bioprinted Human Tissue Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India 3D Bioprinted Human Tissue Market, Segmentation By Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan 3D Bioprinted Human Tissue Market

  • 11.1. Japan 3D Bioprinted Human Tissue Market Overview
  • 11.2. Japan 3D Bioprinted Human Tissue Market, Segmentation By Tissue Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan 3D Bioprinted Human Tissue Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan 3D Bioprinted Human Tissue Market, Segmentation By Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia 3D Bioprinted Human Tissue Market

  • 12.1. Australia 3D Bioprinted Human Tissue Market, Segmentation By Tissue Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia 3D Bioprinted Human Tissue Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia 3D Bioprinted Human Tissue Market, Segmentation By Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia 3D Bioprinted Human Tissue Market

  • 13.1. Indonesia 3D Bioprinted Human Tissue Market, Segmentation By Tissue Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia 3D Bioprinted Human Tissue Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia 3D Bioprinted Human Tissue Market, Segmentation By Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea 3D Bioprinted Human Tissue Market

  • 14.1. South Korea 3D Bioprinted Human Tissue Market Overview
  • 14.2. South Korea 3D Bioprinted Human Tissue Market, Segmentation By Tissue Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea 3D Bioprinted Human Tissue Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea 3D Bioprinted Human Tissue Market, Segmentation By Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe 3D Bioprinted Human Tissue Market

  • 15.1. Western Europe 3D Bioprinted Human Tissue Market Overview
  • 15.2. Western Europe 3D Bioprinted Human Tissue Market, Segmentation By Tissue Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe 3D Bioprinted Human Tissue Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe 3D Bioprinted Human Tissue Market, Segmentation By Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK 3D Bioprinted Human Tissue Market

  • 16.1. UK 3D Bioprinted Human Tissue Market, Segmentation By Tissue Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK 3D Bioprinted Human Tissue Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK 3D Bioprinted Human Tissue Market, Segmentation By Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany 3D Bioprinted Human Tissue Market

  • 17.1. Germany 3D Bioprinted Human Tissue Market, Segmentation By Tissue Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany 3D Bioprinted Human Tissue Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany 3D Bioprinted Human Tissue Market, Segmentation By Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France 3D Bioprinted Human Tissue Market

  • 18.1. France 3D Bioprinted Human Tissue Market, Segmentation By Tissue Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France 3D Bioprinted Human Tissue Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France 3D Bioprinted Human Tissue Market, Segmentation By Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy 3D Bioprinted Human Tissue Market

  • 19.1. Italy 3D Bioprinted Human Tissue Market, Segmentation By Tissue Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy 3D Bioprinted Human Tissue Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy 3D Bioprinted Human Tissue Market, Segmentation By Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain 3D Bioprinted Human Tissue Market

  • 20.1. Spain 3D Bioprinted Human Tissue Market, Segmentation By Tissue Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain 3D Bioprinted Human Tissue Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain 3D Bioprinted Human Tissue Market, Segmentation By Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe 3D Bioprinted Human Tissue Market

  • 21.1. Eastern Europe 3D Bioprinted Human Tissue Market Overview
  • 21.2. Eastern Europe 3D Bioprinted Human Tissue Market, Segmentation By Tissue Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe 3D Bioprinted Human Tissue Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe 3D Bioprinted Human Tissue Market, Segmentation By Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia 3D Bioprinted Human Tissue Market

  • 22.1. Russia 3D Bioprinted Human Tissue Market, Segmentation By Tissue Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia 3D Bioprinted Human Tissue Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia 3D Bioprinted Human Tissue Market, Segmentation By Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America 3D Bioprinted Human Tissue Market

  • 23.1. North America 3D Bioprinted Human Tissue Market Overview
  • 23.2. North America 3D Bioprinted Human Tissue Market, Segmentation By Tissue Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America 3D Bioprinted Human Tissue Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America 3D Bioprinted Human Tissue Market, Segmentation By Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA 3D Bioprinted Human Tissue Market

  • 24.1. USA 3D Bioprinted Human Tissue Market Overview
  • 24.2. USA 3D Bioprinted Human Tissue Market, Segmentation By Tissue Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA 3D Bioprinted Human Tissue Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA 3D Bioprinted Human Tissue Market, Segmentation By Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada 3D Bioprinted Human Tissue Market

  • 25.1. Canada 3D Bioprinted Human Tissue Market Overview
  • 25.2. Canada 3D Bioprinted Human Tissue Market, Segmentation By Tissue Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada 3D Bioprinted Human Tissue Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada 3D Bioprinted Human Tissue Market, Segmentation By Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America 3D Bioprinted Human Tissue Market

  • 26.1. South America 3D Bioprinted Human Tissue Market Overview
  • 26.2. South America 3D Bioprinted Human Tissue Market, Segmentation By Tissue Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America 3D Bioprinted Human Tissue Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America 3D Bioprinted Human Tissue Market, Segmentation By Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil 3D Bioprinted Human Tissue Market

  • 27.1. Brazil 3D Bioprinted Human Tissue Market, Segmentation By Tissue Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil 3D Bioprinted Human Tissue Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil 3D Bioprinted Human Tissue Market, Segmentation By Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East 3D Bioprinted Human Tissue Market

  • 28.1. Middle East 3D Bioprinted Human Tissue Market Overview
  • 28.2. Middle East 3D Bioprinted Human Tissue Market, Segmentation By Tissue Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East 3D Bioprinted Human Tissue Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East 3D Bioprinted Human Tissue Market, Segmentation By Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa 3D Bioprinted Human Tissue Market

  • 29.1. Africa 3D Bioprinted Human Tissue Market Overview
  • 29.2. Africa 3D Bioprinted Human Tissue Market, Segmentation By Tissue Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa 3D Bioprinted Human Tissue Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa 3D Bioprinted Human Tissue Market, Segmentation By Materials, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. 3D Bioprinted Human Tissue Market Competitive Landscape And Company Profiles

  • 30.1. 3D Bioprinted Human Tissue Market Competitive Landscape
  • 30.2. 3D Bioprinted Human Tissue Market Company Profiles
    • 30.2.1. 3D Systems Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Inventia Life Science PTY LTD. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Aspect Biosystems Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Cellink Global AB Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Prellis Biologics Inc. Overview, Products and Services, Strategy and Financial Analysis

31. 3D Bioprinted Human Tissue Market Other Major And Innovative Companies

  • 31.1. Cyfuse Biomedical K.K.
  • 31.2. Poietis SAS
  • 31.3. Fluidform LLC
  • 31.4. Tissuelabs
  • 31.5. Brinter Oy
  • 31.6. EpiBone Inc.
  • 31.7. Carcinotech Ltd.
  • 31.8. VoxCell BioInnovation Inc.
  • 31.9. Organovo Holdings Inc.
  • 31.10. Biolife 4D
  • 31.11. Vivax-bio
  • 31.12. CollPlant Biotechnologies Ltd.
  • 31.13. Xolo
  • 31.14. Copner Biotech
  • 31.15. TissueTinker

32. Global 3D Bioprinted Human Tissue Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The 3D Bioprinted Human Tissue Market

34. Recent Developments In The 3D Bioprinted Human Tissue Market

35. 3D Bioprinted Human Tissue Market High Potential Countries, Segments and Strategies

  • 35.1 3D Bioprinted Human Tissue Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 3D Bioprinted Human Tissue Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 3D Bioprinted Human Tissue Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer